| 000 | 01519 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511212314.0 | ||
| 264 | 0 | _c19910911 | |
| 008 | 199109s 0 0 eng d | ||
| 022 | _a0271-3683 | ||
| 024 | 7 |
_a10.3109/02713689109020377 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPower, W J | |
| 245 | 0 | 0 |
_aBromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration: a double blind controlled study. _h[electronic resource] |
| 260 |
_bCurrent eye research _c1991 |
||
| 300 |
_a183-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBromodeoxyuridine _xanalogs & derivatives |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCorneal Ulcer _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratitis, Dendritic _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aTrifluridine _xtherapeutic use |
| 700 | 1 | _aBenedict-Smith, A | |
| 700 | 1 | _aHillery, M | |
| 700 | 1 | _aBrady, K | |
| 700 | 1 | _aCollum, L M | |
| 773 | 0 |
_tCurrent eye research _gvol. 10 Suppl _gp. 183-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/02713689109020377 _zAvailable from publisher's website |
| 999 |
_c1913731 _d1913731 |
||